Biotechnology Josh Brown Just Bought This Stock Trading At 11-Year Lows, Paying A 6.5% Dividend: ‘They Always Find A Way To Rebuild’ – Pfizer (NYSE:PFE) Read more
Biotechnology Pfizer/GSK-Backed ViiV Healthcare’s HIV Drug Associated With Increased Resistance, WHO Report Says – GSK (NYSE:GSK), Pfizer (NYSE:PFE) Read more
Biotechnology Pfizer’s Respiratory Syncytial Virus Vaccine Maintains Staying Power In Older Adults Through 2nd RSV season, Study Finds – Pfizer (NYSE:PFE) Read more
Biotechnology Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment – Pfizer (NYSE:PFE) Read more
Biotechnology Pfizer’s Mixed Bag: A Look At The Fourth Quarter 2023 Earnings Call – Main Takeaways – Pfizer (NYSE:PFE) Read more
Biotechnology Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle – Pfizer (NYSE:PFE) Read more
Biotechnology Pfizer Surprises With Q4 Profit Despite Muted COVID Products Demand, Sticks To 2024 Guidance – Pfizer (NYSE:PFE) Read more
Biotechnology Pfizer’s COVID-19 Treatment Paxlovid Will No Longer Be Available For Emergency Use After This Date, FDA Revises Label – Pfizer (NYSE:PFE) Read more